Published on: May 20, 2025
Shares of Newgen Software Technologies surged 7% to ₹1,232.90 on the BSE in intraday trading on Tuesday, even as the broader market, represented by the BSE Sensex, slipped 0.25% to 81,856. The rally marks a sharp turnaround for the AI-first digital transformation company, with its stock gaining 25% in May and rebounding 67% from a monthly low of ₹740.05 touched on April 7, 2025.
The stock has been in focus after a series of positive developments. On May 16, Newgen received a patent for its "System and Method for Data Compression" from the Indian patent office. The innovation is designed for efficient compression of large data sets with recurring patterns—an area where traditional techniques often fall short.
Additionally, Newgen's Saudi Arabian subsidiary signed a $1.632 million agreement on May 12 to deliver software licenses and services, including annual technical support, which is expected to strengthen its presence in the Middle East.
Financially, the company reported a 2.9% year-on-year rise in consolidated net profit to ₹108.3 crore in Q4FY25. Revenue rose 14.6% YoY to ₹429.90 crore, led by robust growth in the APAC and US markets. Management highlighted strong deal wins in the US and expressed confidence in continued momentum across global markets.
Newgen continues to drive its AI-first strategy, investing heavily in intelligent automation and launching new AI agents—Lumyn, Harper, and Marvin—which have already shown strong early use cases. With its low-code, cloud-based digital transformation platform, Newgen remains a preferred partner for enterprises seeking agile, content-driven solutions across sectors such as banking, insurance, and government.
The company hit its 52-week high of ₹1,795.50 on January 15, 2025, and is regaining traction as investor confidence builds around its innovation roadmap and global expansion efforts.
Published on: May 20, 2025
India’s largest real estate developer by market capitalization, DLF Ltd, plans to launch residential projects worth over ₹17,000 crore in FY2025-26, aiming to tap into the robust demand for luxury housing. The company made the announcement in its latest investor presentation, citing strong momentum in the high-end real estate market.
In FY2024-25, DLF launched 7.5 million square feet of saleable area with an estimated revenue potential of ₹40,600 crore, selling 5 million square feet for ₹19,344 crore during the year. Among its key launches was the super-luxury project ‘The Dahlias’, spanning 4.5 million sq. ft. with a potential of ₹35,000 crore. The project alone generated ₹13,744 crore in sales bookings within its first year—about 39% of its total projected value.
Buoyed by this success, DLF recorded all-time high sales bookings of ₹21,223 crore in FY25, a 44% jump from ₹14,778 crore in FY24. The company has laid out a medium-term development plan of 37 million sq. ft. with a revenue potential of ₹1.14 lakh crore, of which 35% has already been launched and 15% is scheduled for FY26.
Financially, DLF posted a 39% year-on-year rise in net profit for the January–March 2025 quarter to ₹1,282.2 crore. For the full fiscal year, net profit surged to ₹4,366.82 crore from ₹2,723.53 crore, while total income grew to ₹8,995.89 crore from ₹6,958.34 crore in FY24.
Since inception, DLF has developed over 185 projects across more than 352 million sq. ft., with a current development potential of 280 million sq. ft. across residential and commercial segments. The group also holds a 45 million sq. ft. annuity portfolio, reinforcing its leadership in both the development and leasing businesses.
Published on: May 20, 2025
Shares of New Delhi Television (NDTV) soared 18% on Tuesday to hit a five-month high of ₹174.05 on the BSE, continuing their strong upward momentum. The stock has now rallied 43% over the past week and has rebounded 74% from its April 2025 low of ₹100.10. At 11:07 AM, shares were trading 15% higher at ₹168.80, supported by a seven-fold increase in trading volumes.
This sharp rally comes on the heels of multiple positive developments. Credit agency CARE Ratings on May 19 assigned 'CARE A-/Stable' and 'CARE A2' ratings to NDTV’s long- and short-term bank facilities, citing strong parentage under Adani Enterprises Ltd. (AEL), long-standing industry presence, and operational support from its parent company.
NDTV, now part of the Adani Group through AMG Media Networks, has been expanding its footprint with three new regional channels—NDTV Rajasthan, NDTV MPCG, and NDTV Marathi—as well as a relaunch of NDTV Profit. This regional push, coupled with the return of BARC ratings from November 2024, has boosted advertising revenues significantly.
In Q4 FY25, NDTV reported 19% year-on-year revenue growth, fueled by extensive coverage of national events like the Mahakumbh and Delhi Elections. Despite a bottom-line loss for the year, the company emphasized that strategic investments in technology, brand building, and digital modernization are aimed at long-term value creation.
NDTV has also proposed a merger of its subsidiaries—NDTV Networks, NDTV Media, NDTV Labs, and NDTV Worldwide—excluding NDTV Convergence, to streamline operations. CARE Ratings believes the merger will have no material adverse impact on operations.
With a strengthened financial profile, aggressive regional expansion, and digital transformation underway, NDTV is positioning itself for long-term growth under the Adani umbrella.
Published on: May 20, 2025
Aditya Birla Group's flagship metal company, Hindalco Industries, reported a 66% year-on-year jump in consolidated net profit to ₹5,284 crore for the quarter ended March 2025. The company had posted a net profit of ₹3,174 crore in the same period last year.
Hindalco attributed the sharp rise in profitability to a strong showing by its Indian operations, bolstered by supportive macroeconomic factors and a decline in input costs.
Consolidated revenue from operations also saw a notable increase, rising to ₹64,890 crore in Q4 FY25 from ₹55,994 crore in the corresponding quarter of the previous fiscal year, reflecting broad-based growth across key segments.
Published on: May 20, 2025
Moody’s Ratings on Tuesday cautioned that ongoing unpredictability in US trade policy, particularly around tariffs, poses significant credit risks for debt issuers in emerging markets. The rating agency noted that the "on-again, off-again" nature of US tariffs, combined with broader geopolitical tensions—including recent India-Pakistan friction—adds stress for companies, governments, and banks in these economies.
While exporters to the US are directly exposed to tariff changes, Moody’s highlighted that most emerging market debt issuers face indirect consequences such as slower economic growth, currency depreciation, declining commodity prices, and rising investor risk aversion.
In April, the US announced sweeping, country-specific tariffs, which were later paused for 90 days, while maintaining a base 10% tariff and higher rates on sectors like steel and aluminum. Tariffs on Chinese goods soared to 145%, prompting reciprocal action from China. A temporary agreement in May eased some tariffs for 90 days, but Moody’s noted that broader trade uncertainties remain.
Despite recent progress in US-China and US-UK tariff agreements, Moody’s said a full rollback of tariffs is unlikely. The ongoing uncertainty will continue to weigh on consumer confidence, business investment, and financial activity across emerging markets.
Published on: May 20, 2025
Shares of IndusInd Bank are likely to be in focus after a Reuters report revealed that the Securities and Exchange Board of India (SEBI) is investigating six of the bank’s officials for alleged insider trading. According to sources familiar with the matter, the officials may have sold employee stock options while aware of significant accounting irregularities—prior to this information becoming public.
The regulator is examining the timing of these trades to determine possible violations of insider trading laws and the bank’s internal code of conduct. The investigation is still in its early stages, and no show-cause notices have been issued so far.
This development follows a forensic review by Grant Thornton, which found that two IndusInd Bank executives traded in the bank’s shares despite knowledge of accounting discrepancies. SEBI has reportedly sought a copy of this report.
In March, the bank disclosed a $230 million discrepancy stemming from years of misaccounting internal derivative trades. This revelation led to the resignations of CEO Sumant Kathpalia and Deputy CEO Arun Khurana in April.
SEBI is also questioning the bank over delays in disclosing the issue, which sources claim may have been known internally since September 2024. Any proven violations could lead to penalties, bans, or claw-backs of bonuses and stock options under both SEBI norms and the bank’s code of conduct.
Published on: May 20, 2025
Nomura has reiterated a ‘buy’ rating on Godrej Consumer Products Ltd. (GCPL), raising its target price to Rs 1,485, implying a potential upside of 14.2%. The brokerage is optimistic about GCPL’s growth trajectory, driven by its strategic focus on future-facing and disruptive product categories.
At GCPL’s recent annual analyst meet, the company unveiled multiple innovations such as the Rs 99 launch of KS Spark deodorants—significantly below the market average price of Rs 230—entry into the antiperspirant segment with the new Godrej Block brand for men, and a new Eau de Parfum range with compact, long-lasting packs. The company also entered the gifting segment and launched Amazon Woods, a premium no-gas body spray priced 3-4% below competitors, targeting market premiumisation.
GCPL has diversified into pet care, introducing products like pet shampoo, and expanded its home care portfolio with new launches including 'Aer Plug' and aerosols priced competitively at Rs 99. Nomura views these moves as positioning GCPL strongly in the air, hair, and household insecticide segments.
Looking ahead to fiscal 2026, Nomura forecasts mid-to-high single-digit volume growth in India and double-digit consolidated EBITDA growth, even as margin pressures from high palm oil prices temper expectations slightly. The brokerage has trimmed EBITDA estimates for fiscals 2026 and 2027 by 2-4%, yet remains confident in GCPL’s growth and innovation-driven strategy.
Despite trading at a rich valuation of 51 times March 2027 EPS, Nomura justifies its bullish stance based on GCPL’s continued investments in brand innovation and premiumisation. The target price is based on a 40 times enterprise value to EBITDA multiple. The key risk flagged is slower-than-expected volume growth.
Overall, GCPL’s bold product launches and diversification efforts underpin Nomura’s positive outlook on the company’s long-term potential.
Published on: May 20, 2025
Shares of Pfizer Ltd rallied sharply on Tuesday, May 20, 2025, rising 11.33% to an intraday high of ₹4,970.40, after the pharmaceutical major reported robust March quarter results and a massive dividend payout. As of 9:38 AM, the stock was trading close to its high at ₹4,968.40, significantly outperforming the BSE Sensex, which was flat at 82,075.72.
For the March quarter of FY25, Pfizer’s net profit jumped 85% year-on-year to ₹331 crore, up from ₹179 crore in Q4FY24. Revenue rose 8.3% YoY to ₹591.9 crore, while EBITDA surged 20.1% to ₹227.5 crore, with margins expanding to 38.4% from 34.7% a year ago—indicating improved operational efficiency.
In a major shareholder-friendly move, the Board declared a total dividend of ₹165 per share. This includes:
• ₹35 final dividend (350%)
• ₹100 special dividend marking Pfizer's 75th year in India
• ₹30 special dividend from gain on transfer of leasehold land and building
The record date for dividend entitlement is set as July 9, 2025.
Pfizer, a global pharmaceutical leader headquartered in New York, has a significant presence in India with operations spanning key therapeutic areas like vaccines, oncology, internal medicine, and rare diseases. Its Goa facility plays a critical role in both domestic and global supply chains. The company is also known for its iconic COVID-19 vaccine using mRNA technology and popular consumer health products like Centrum and Advil.
This performance reinforces Pfizer’s strong fundamentals and commitment to delivering both medical innovation and shareholder value, as it continues its legacy in India and beyond.
Published on: May 19, 2025
Investors brace for a data‑packed session on 19 May when 98 listed companies—including blue‑chips Power Grid Corp. of India (PGCIL) and Bharat Electronics (BEL)—report fourth‑quarter and full‑year FY25 results. Heavyweights ONGC, DLF, Pfizer India, New India Assurance, NLC India, PI Industries, Gujarat Gas, and Hindalco headline a diverse line‑up that also features Dixon Technologies, Borosil, Everest Industries, Dredging Corp. and Piccadily Agro.
The earnings barrage arrives after the Sensex and Nifty50 slipped 0.24 % and 0.17 %, respectively, on Friday amid profit‑taking at record levels. Early indicators point to a muted start: GIFT Nifty traded 16 points lower at 25,063 around 7:50 a.m., suggesting a flat opening in the absence of clear global cues.
With sectors from power and defence to real estate and pharma on deck, stock‑specific volatility is likely to dominate Monday’s trade as the market digests headline growth, margin trends and FY26 guidance from the final major batch of March‑quarter reporters.
Published on: May 19, 2025
The road to the bourses has opened for two Coal India Ltd. (CIL) units—Bharat Coking Coal Ltd. (BCCL) and Central Mine Planning & Design Institute (CMPDI)—with draft red herring prospectuses (DRHPs) set to be filed “soon,” CIL Director‑Business Development Debasish Nanda said on Monday at the CII Mining & Construction Equipment Summit. Book‑running lead managers have just been appointed, signalling that IPO groundwork is under way; timing will hinge on market conditions, the Coal Ministry earlier noted.
Listing the pair would mark the first public‑market spin‑offs from CIL’s stable of seven producing subsidiaries and one consultancy arm. BCCL contributes premium coking coal, key for steelmakers, while CMPDI provides technical and exploration services.
The parent miner, which supplies over 80 % of India’s coal, just posted a 12 % YoY jump in March‑quarter consolidated net profit to ₹9,604 crore on revenue of ₹41,762 crore. Output, however, has plateaued—April production was flat at 62.1 Mt, and FY 2024‑25 output of 781 Mt fell short of targets. CIL aims to lift production to 875 Mt and despatch 900 Mt in FY 2025‑26. Proceeds from the IPOs could bolster expansion capex as India pushes to meet rising power‑sector demand while reducing imports of coking coal.
Published on: May 19, 2025
The codename “Operation Sindoor,” used for India’s 7 May coordinated missile strikes on terrorist targets in Pakistan and Pakistan occupied Kashmir, has become the focus of a trademark land grab on three continents. Legal database checks show:
• India: Fourteen applications lodged under multiple Nice classes, chiefly Class 41 (media, cultural and entertainment services). One filing lists Reliance Industries among four applicants, though the company later said it has no intent to trademark the term.
• United States: New Yorker Rohith Baharani filed on 9 May under Class 041 for future licensing of an entertainment title. The USPTO filing is on an “intent to use” basis and awaits examination.
• United Kingdom: Devon resident Vikas Mahajan filed on 8 May across Classes 35, 38 and 41, covering advertising, telecom and educational services.
Bar & Bench reports at least 13 distinct parties have sought rights globally by mid May. Because India offers no automatic IP protection for military operation names, private entities can pursue trademarks unless the government intervenes, raising the prospect of conflicting claims over a label linked to national security action.
Published on: May 19, 2025
Investors cheered twin turnarounds on 19 May as Divi’s Laboratories and Delhivery Ltd. each posted their first full year profits, sending the shares up roughly 6 % and 12 % respectively to hit BSE upper circuits.
• Divi’s Laboratories
• Q4 FY25 revenue up 12 % YoY; PAT up 23 % to ₹662 crore.
• EBITDA rose 21 % to ₹886 crore; margin expanded to 34.3 % from 31.7 %.
• Management guides for double digit revenue growth in FY26; market cap nears ₹1.75 trillion.
• Zee Business’ Anil Singhvi calls Divi’s a “quiet performer” and sees the stock “ultimately crossing five digits” on sustained execution.
• Delhivery Ltd.
• Q4 revenue climbed 9 % YoY; PAT swung to ₹72.6 crore from a ₹68.5 crore loss.
• EBITDA jumped 159 % to ₹119 crore, signalling tighter cost control and scale benefits.
• Singhvi says the logistics firm “has entered a new phase of growth,” poised to draw fresh institutional interest.
Labelled “high beta plays for FY26,” both counters have shed their loss making tag and now boast improving cash flows. With margins firming at Divi’s and operating leverage kicking in at Delhivery, Singhvi argues the duo could continue outperforming in the quarters ahead as investors hunt for profitable growth stories.
Published on: May 19, 2025
Shares of Divi’s Laboratories Ltd. surged 5 % to a lifetime peak of ₹6,596.80 on the BSE early Monday, outpacing a marginally weaker Sensex. The rally followed stronger‑than‑expected March‑quarter results released over the weekend:
• Q4 FY25 highlights:
• Revenue rose 12 % YoY to ₹2,585 crore.
• Net profit jumped 23 % to ₹662 crore, beating estimates on better operating leverage.
• Both the custom synthesis and generics API segments returned to double digit growth, the latter snapping an eight quarter lull.
• Shareholder reward: The board proposed a ₹30 per share final dividend (1,500 % of face value), with 25 July 2025 set as the record date.
Brokerage Motilal Oswal maintained a ‘Neutral’ stance but raised FY26/FY27 earnings forecasts by 5 % 7 %, citing fresh long term CS contracts, easing input costs and stronger generic execution, pegging fair value at ₹6,540.
With Monday’s move the stock is now up 70 % from its 52 week low of ₹3,860, adding to a market cap of roughly ₹1.74 trillion. Trading volumes and an RSI near overbought territory signal robust investor appetite as Divi’s reinforces its stature in high margin custom chemistry while capitalising on a revival in generic APIs.
Published on: May 19, 2025
India’s capital‑markets watchdog, the Securities and Exchange Board of India (SEBI), has opened an insider‑trading investigation into six senior officials of IndusInd Bank, probing whether they exercised and sold employee stock‑option (ESOP) shares while privately aware of long‑running derivative‑accounting errors that the bank disclosed only in March.
Sources with direct knowledge told Reuters that SEBI is scrutinising trade dates against internal communications and the Grant Thornton forensic report that first flagged “years of incorrect accounting of internal derivative trades,” which left a $230 million hole in the lender’s ₹60.8‑trillion balance sheet. SEBI has formally requested that report from the bank.
The review follows resignations of CEO Sumant Kathpalia and deputy chief Arun Khurana last month and comes amid fresh downgrades from brokerage houses and a “watch negative” outlook on the bank’s long‑term ratings by CRISIL. While SEBI has yet to issue show‑cause notices, potential penalties range from monetary fines to trading bans; IndusInd’s own code allows claw‑backs of bonuses and ESOPs for such violations.
Separately, the regulator has asked the bank to justify why the accounting lapses—known internally since at least September 2024—were not disclosed sooner. IndusInd shares edged up 0.22 % on Monday ahead of the news.
Published on: May 19, 2025
State Bank of India (SBI) has lowered interest rates on retail domestic term deposits (amounts below ₹3 crore) by 20 basis points across all maturities, according to the revised rate card posted on its website. The change took effect on 16 May 2025.
Under the new slab, the highest return is 6.70 % for deposits with a tenor of 2 years to less than 3 years, while the 3‑to‑5‑year bucket now fetches 6.55 %. Rates for senior citizens have been reduced by the same margin, preserving their usual 50‑basis‑point premium over public rates.
The cut comes amid abundant banking‑system liquidity and expectations that the Reserve Bank of India may stay on hold longer, prompting large lenders to fine‑tune deposit costs after a year of aggressive rate hikes. Customers locking in fresh FDs—or renewing existing ones—will earn interest at the revised levels starting 16 May.